[go: up one dir, main page]

MA46548B1 - Fsh pour le traitement de l'infertilité - Google Patents

Fsh pour le traitement de l'infertilité

Info

Publication number
MA46548B1
MA46548B1 MA46548A MA46548A MA46548B1 MA 46548 B1 MA46548 B1 MA 46548B1 MA 46548 A MA46548 A MA 46548A MA 46548 A MA46548 A MA 46548A MA 46548 B1 MA46548 B1 MA 46548B1
Authority
MA
Morocco
Prior art keywords
fsh
infertility
treatment
relates
present
Prior art date
Application number
MA46548A
Other languages
English (en)
Other versions
MA46548A (fr
Inventor
Saez Joan Carlos Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MA46548A publication Critical patent/MA46548A/fr
Publication of MA46548B1 publication Critical patent/MA46548B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des préparations contenant de la fsh, par exemple de la fsh recombinante, pouvant être utilisées dans le traitement de l'infertilité.
MA46548A 2015-04-17 2016-04-15 Fsh pour le traitement de l'infertilité MA46548B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15164043 2015-04-17
PCT/EP2016/058358 WO2016166288A1 (fr) 2015-04-17 2016-04-15 Composition pour le traitement de l'infertilité
EP16719315.0A EP3283097B1 (fr) 2015-04-17 2016-04-15 Fsh pour le traitement de l'infertilité

Publications (2)

Publication Number Publication Date
MA46548A MA46548A (fr) 2018-02-21
MA46548B1 true MA46548B1 (fr) 2020-03-31

Family

ID=52997893

Family Applications (1)

Application Number Title Priority Date Filing Date
MA46548A MA46548B1 (fr) 2015-04-17 2016-04-15 Fsh pour le traitement de l'infertilité

Country Status (17)

Country Link
US (3) US10660938B2 (fr)
EP (2) EP3662925B1 (fr)
JP (2) JP7079094B2 (fr)
KR (2) KR20170137041A (fr)
CN (1) CN107405385A (fr)
AU (1) AU2016247498B2 (fr)
CA (1) CA2975444A1 (fr)
DK (2) DK3662925T3 (fr)
ES (2) ES2784625T3 (fr)
HU (2) HUE048757T2 (fr)
MA (1) MA46548B1 (fr)
MX (1) MX2017010883A (fr)
PL (2) PL3283097T3 (fr)
PT (2) PT3283097T (fr)
RU (1) RU2704252C2 (fr)
SI (2) SI3283097T1 (fr)
WO (1) WO2016166288A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016102436A1 (fr) * 2014-12-22 2016-06-30 F. Hoffmann-La Roche Ag Activité sialidase cmp-dépendante
KR20170137041A (ko) 2015-04-17 2017-12-12 훼링 비.브이. 불임 치료용 조성물
HRP20211802T1 (hr) * 2017-09-01 2022-03-04 Ferring B.V. Pripravak za kontroliranu stimulaciju jajnika
PL3787667T3 (pl) * 2018-04-30 2025-07-28 Ferring B.V. Kompozycja do kontrolowanej stymulacji jajników
CN120349426A (zh) 2018-06-22 2025-07-22 科优基因公司 白介素-2变体及其使用方法
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
US20250241993A1 (en) * 2022-04-01 2025-07-31 Ferring B.V. Mixed protocol for treatment of infertility

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228973B (de) * 1961-05-13 1966-11-17 Skf Kugellagerfabriken Gmbh Streckwerk fuer Spinnereimaschinen
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
KR20170137041A (ko) 2015-04-17 2017-12-12 훼링 비.브이. 불임 치료용 조성물

Also Published As

Publication number Publication date
KR20170137041A (ko) 2017-12-12
RU2017128296A (ru) 2019-05-17
US20180125942A1 (en) 2018-05-10
DK3283097T3 (da) 2020-04-20
EP3662925B1 (fr) 2021-04-07
US20200353053A1 (en) 2020-11-12
PT3662925T (pt) 2021-07-01
JP2018513161A (ja) 2018-05-24
HUE054300T2 (hu) 2021-08-30
SI3283097T1 (sl) 2020-06-30
EP3662925A1 (fr) 2020-06-10
US10660938B2 (en) 2020-05-26
MA46548A (fr) 2018-02-21
JP2021020915A (ja) 2021-02-18
CA2975444A1 (fr) 2016-10-20
CN107405385A (zh) 2017-11-28
RU2704252C2 (ru) 2019-10-25
WO2016166288A1 (fr) 2016-10-20
PL3283097T3 (pl) 2020-10-19
US11439686B2 (en) 2022-09-13
EP3283097B1 (fr) 2020-02-12
SI3662925T1 (sl) 2021-08-31
AU2016247498B2 (en) 2021-06-03
EP3283097A1 (fr) 2018-02-21
KR20240073153A (ko) 2024-05-24
RU2017128296A3 (fr) 2019-06-25
JP7161511B2 (ja) 2022-10-26
JP7079094B2 (ja) 2022-06-01
HUE048757T2 (hu) 2020-08-28
PL3662925T3 (pl) 2021-10-25
US20230139407A1 (en) 2023-05-04
PT3283097T (pt) 2020-04-06
DK3662925T3 (da) 2021-06-28
AU2016247498A1 (en) 2017-08-17
ES2879838T3 (es) 2021-11-23
MX2017010883A (es) 2017-12-07
ES2784625T3 (es) 2020-09-29

Similar Documents

Publication Publication Date Title
MA46548A (fr) Fsh pour le traitement de l'infertilité
MA41013B1 (fr) Compositions comprenant des souches bactériennes
MA41977B1 (fr) Imidazopyrazinones utilisées comme inhibiteurs de pde1
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
EA201990043A1 (ru) Антибактериальные соединения
MA44659B1 (fr) Anticorps anti-tim-3 et compositions
MA43335B1 (fr) Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
GEP20207151B (en) Agents, Uses and Methods for the Treatment of Synucleinopathy
MA44322A (fr) Compositions comprenant des souches bactériennes
EA201890204A1 (ru) Антибактериальные соединения
EA201891268A1 (ru) Соединения, которые можно применять в качестве ингибиторов киназы
MX383213B (es) Inhibidores de tirosina-cinasas
MA42471A (fr) Compositions comprenant des souches bactériennes
EA201892123A1 (ru) 6-гидрокси-4-оксо-1,4-дигидропиримидин-5-карбоксамиды в качестве агонистов apj
PE20180189A1 (es) Composiciones y metodos para el tratamiento de la anemia
EA201890858A1 (ru) 2,4-дигидроксиникотинамиды как агонисты apj
EA201891336A1 (ru) Гетероарилгидроксипиримидиноны в качестве агонистов рецептора apj
MA52216B1 (fr) Mirikizumab pour le traitement de la colite ulcéreuse
MA41758B1 (fr) Procédés de traitement de l'infertilité
EP3541379A4 (fr) Compositions pour le traitement de l'hypertension
EA202090944A1 (ru) Анти-cd3-антитело и фармацевтическая композиция для лечения онкологических заболеваний, содержащая его
EA201990998A1 (ru) Фармацевтические составы и способы их получения
MA52920B1 (fr) Compositions et procédés se rapportant à des agonistes de pyridinoylpipéridine 5-ht1f
EA202090945A1 (ru) Анти-msln-антитело и фармацевтическая композиция для лечения онкологических заболеваний, содержащая его
MA39837B1 (fr) Quinazoline-thf-amines halogénées en tant qu'inhibiteurs de la pde1